Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lana McClements

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Toxins|July 26, 2019
Association of <i>Nrf2</i>, <i>SOD2</i> and <i>GPX1</i> Polymorphisms with Biomarkers of Oxidative Distress and Survival in End-Stage Renal Disease PatientsDjurdja Jerotic, Marija Matic, Sonja Suvakov, et al.
Biomolecules|February 25, 2023
FK506-Binding Protein like (FKBPL) Has an Important Role in Heart Failure with Preserved Ejection Fraction Pathogenesis with Potential Diagnostic UtilityMichael Chhor, Hao Chen, Djurdja Jerotić, et al.
BMC Cancer|April 13, 2019
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4Lana McClements, Stephanie Annett, Anita Yakkundi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 2026
Systemic Loss of FKBPL Uncovers Diabetes-Dependent Pathways of Myocardial and Vascular InjuryAbdelrahim Alqudah, Kevin S Edgar, Karla M O'Neill, et al.
Biology of Sex Differences|April 21, 2021
Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsiaClaire Richards, Kimberly Sesperez, Michael Chhor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathwayLana McClements, Anita Yakkundi, Angelos Papaspyropoulos, et al.
American Journal of Nephrology|June 26, 2019
Markers of Oxidative Stress and Endothelial Dysfunction Predict Haemodialysis Patients SurvivalSonja Suvakov, Djurdja Jerotic, Tatjana Damjanovic, et al.
Nature Communications|September 12, 2025
Matrix directs trophoblast differentiation in a bioprinted organoid model of early placental developmentClaire Richards, Hao Chen, Matthew O'Rourke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 14, 2015
FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesisAnita Yakkundi, Rachel Bennett, Ivette Hernández-Negrete, et al.
Cellular and Molecular Life Sciences : CMLS|January 18, 2023
A placenta-on-a-chip model to determine the regulation of FKBPL and galectin-3 in preeclampsiaSahar Masoumeh Ghorbanpour, Claire Richards, Dillan Pienaar, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Toxins|July 26, 2019
Association of <i>Nrf2</i>, <i>SOD2</i> and <i>GPX1</i> Polymorphisms with Biomarkers of Oxidative Distress and Survival in End-Stage Renal Disease PatientsDjurdja Jerotic, Marija Matic, Sonja Suvakov, et al.
Biomolecules|February 25, 2023
FK506-Binding Protein like (FKBPL) Has an Important Role in Heart Failure with Preserved Ejection Fraction Pathogenesis with Potential Diagnostic UtilityMichael Chhor, Hao Chen, Djurdja Jerotić, et al.
BMC Cancer|April 13, 2019
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4Lana McClements, Stephanie Annett, Anita Yakkundi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 12, 2026
Systemic Loss of FKBPL Uncovers Diabetes-Dependent Pathways of Myocardial and Vascular InjuryAbdelrahim Alqudah, Kevin S Edgar, Karla M O'Neill, et al.
Biology of Sex Differences|April 21, 2021
Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsiaClaire Richards, Kimberly Sesperez, Michael Chhor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathwayLana McClements, Anita Yakkundi, Angelos Papaspyropoulos, et al.
American Journal of Nephrology|June 26, 2019
Markers of Oxidative Stress and Endothelial Dysfunction Predict Haemodialysis Patients SurvivalSonja Suvakov, Djurdja Jerotic, Tatjana Damjanovic, et al.
Nature Communications|September 12, 2025
Matrix directs trophoblast differentiation in a bioprinted organoid model of early placental developmentClaire Richards, Hao Chen, Matthew O'Rourke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 14, 2015
FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesisAnita Yakkundi, Rachel Bennett, Ivette Hernández-Negrete, et al.
Cellular and Molecular Life Sciences : CMLS|January 18, 2023
A placenta-on-a-chip model to determine the regulation of FKBPL and galectin-3 in preeclampsiaSahar Masoumeh Ghorbanpour, Claire Richards, Dillan Pienaar, et al.
Pageof 7